Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Cann Group Limited	CVJ	17. mai 2024	0.03	0.00
Cannabis Poland S.A.	8TE	17. mai 2024	0.14	-16.98
CanSino Biologics Inc.	CJH	17. mai 2024	2.48	0.00
Chemical Works of Gedeon Richter Plc.	RIG2	17. mai 2024	24.08	-0.41
China Resources Pharmaceutical Group Limited	640	17. mai 2024	0.71	-0.69
Chugai Pharmaceutical Co Ltd	CUP	17. mai 2024	28.98	+0.66
CMS	2M7C	17. mai 2024	0.81	+0.63
CONSUN PHARMA	C1P	17. mai 2024	0.68	0.00
COSMO Pharmaceuticals N.V.	C43	17. mai 2024	73.00	-0.68
CSPC PHARMA	CVG	17. mai 2024	0.76	-1.91
CSPC Pharmaceuticals Group Ltd American Depositary Receipts	CVGU	17. mai 2024	3.00	-0.66
Daiichi Sankyo Co., Ltd.	D4S	17. mai 2024	32.17	-1.62
Eco Animal Health Group Plc	LWA	17. mai 2024	1.33	0.00
Eisai Co Ltd	EII	17. mai 2024	40.85	+1.11
Elixinol Global Ltd Ordinary Shares (Australia)	E8M	17. mai 2024	0.00	0.00
FOSUN PHARMA	08HH	17. mai 2024	1.54	-0.19
FUDANZHANGJIANG	FDY	17. mai 2024	0.25	-0.79
Fuji Pharma Co., Ltd.	FUP	17. mai 2024	8.90	0.00
Genomma Lab Internacional SAB	GEKA	17. mai 2024	0.91	-0.55
Hisamitsu Pharmaceutical Co Ltd	HPX	17. mai 2024	21.80	-0.91
Invion Limited	7C8	17. mai 2024	0.00	0.00
Kalbe Farma Tbk	LCLA	17. mai 2024	0.08	+3.95
Kyowa Kirin Co. Ltd.	KY4	17. mai 2024	15.20	-1.94
Laboratorio Reig Jofre S.A.	FEQ1	17. mai 2024	2.68	+0.75
LEES PHARM	L1PA	17. mai 2024	0.13	0.00
LIVZON PHARMA	LP6	17. mai 2024	3.24	-2.41
Luye Pharma Group Ltd	LUP	17. mai 2024	0.35	+1.16
Mayne Pharma Group Limited	HG6	17. mai 2024	3.84	+1.59
Merck KGAA	MRKC	17. mai 2024	33.00	+1.85
MGC Pharmaceuticals Ltd	H5O	17. mai 2024	0.21	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.